Literature DB >> 1438617

Electroretinography in seasonal affective disorder.

R W Lam1, C W Beattie, A Buchanan, J A Mador.   

Abstract

Retinal mechanisms have been hypothesized in the pathophysiology of seasonal affective disorder (SAD). Electroretinography (ERG) is a noninvasive electrophysiologic test that provides an objective measure of photoreceptor and retinal function. We conducted dark-adapted ERG examinations with a bright white light stimulus in a group of depressed, drug-free patients with seasonal affective disorder (6 men, 18 women) diagnosed by DSM-III-R criteria, and a group of sex- and age-matched control subjects (6 men, 16 women) during the winter. A significant difference was found between SAD patients and controls, but female SAD patients had lower ERG b-wave amplitudes than female controls, while male SAD patients had higher amplitudes than the matched controls. The ERG b-wave implicit times (times from onset of stimulus to peak of b-wave) were significantly longer in the left eyes of the male control subjects. These data may indicate subtle retinal changes in patients with SAD, but the results must be considered preliminary because of the small number of subjects studied and the large intersubject variability in the ERG procedure.

Entities:  

Mesh:

Year:  1992        PMID: 1438617     DOI: 10.1016/0165-1781(92)90141-o

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

Review 1.  Pathophysiology of seasonal affective disorder: a review.

Authors:  R W Lam; R D Levitan
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  The post illumination pupil response is reduced in seasonal affective disorder.

Authors:  Kathryn Roecklein; Patricia Wong; Natalie Ernecoff; Megan Miller; Shannon Donofry; Marissa Kamarck; W Michael Wood-Vasey; Peter Franzen
Journal:  Psychiatry Res       Date:  2013-07-01       Impact factor: 3.222

3.  Light-Regulated Thyroid Hormone Signaling Is Required for Rod Photoreceptor Development in the Mouse Retina.

Authors:  Onkar Sawant; Amanda M Horton; Meenal Shukla; Mary E Rayborn; Neal S Peachey; Joe G Hollyfield; Sujata Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

4.  Circadian perinatal photoperiod has enduring effects on retinal dopamine and visual function.

Authors:  Chad R Jackson; Megan Capozzi; Heng Dai; Douglas G McMahon
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

5.  A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Authors:  Michele Fornaro; Davide Prestia; Salvatore Colicchio; Giulio Perugi
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

6.  Melanopsin gene variations interact with season to predict sleep onset and chronotype.

Authors:  Kathryn A Roecklein; Patricia M Wong; Peter L Franzen; Brant P Hasler; W Michael Wood-Vasey; Vishwajit L Nimgaonkar; Megan A Miller; Kyle M Kepreos; Robert E Ferrell; Stephen B Manuck
Journal:  Chronobiol Int       Date:  2012-08-10       Impact factor: 2.877

Review 7.  Melanopsin, photosensitive ganglion cells, and seasonal affective disorder.

Authors:  Kathryn A Roecklein; Patricia M Wong; Megan A Miller; Shannon D Donofry; Marissa L Kamarck; George C Brainard
Journal:  Neurosci Biobehav Rev       Date:  2012-12-31       Impact factor: 8.989

8.  Photoperiodic regulation of dopamine signaling regulates seasonal changes in retinal photosensitivity in mice.

Authors:  Kousuke Okimura; Yusuke Nakane; Taeko Nishiwaki-Ohkawa; Takashi Yoshimura
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

9.  Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

Authors:  Michele Fornaro; Fabio Bandini; Luca Cestari; Christian Cordano; Carla Ogliastro; Claudio Albano; Domenico De Berardis; Matteo Martino; Andrea Escelsior; Giulio Rocchi; Pantaleo Fornaro; Concetta De Pasquale
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-20       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.